Abate Kristin bought KPTI
October 15, 2025 · Form 4 insider transaction
Abate Kristin bought 12,799 shares of Karyopharm Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
12,799
Price
$0.00
Total value
N/A
InsiderAbate Kristin
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 15, 2025
Filing dateOctober 16, 2025
Shares owned after22,845
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as follows: 2,799 RSUs vest in two equal annual installments beginning October 31, 2026, and 10,000 RSUs vest 100% on October 15, 2026.